Search This Blog

Tuesday, November 5, 2019

Intercept Pharma EPS misses by $0.19, misses on revenue

Intercept Pharma (NASDAQ:ICPT): Q3 GAAP EPS of -$2.59 misses by $0.19.
Revenue of $61.95M (+32.1% Y/Y) misses by $1.58M.
Shares +0.2% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)